Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

Researchers identify intervention strategies to curb consumption of energy drinks

Because many countries allow the sale of energy drinks to young people, identifying ways to minimize potential harm from energy drinks is critical. A new study published in the Journal of Nutrition Education and Behavior provided unique insights into intervention strategies suggested by young people themselves to reduce consumption.

5 Oct 2017

Plant extracts may help protect against negative effects of X-ray irradiation

A compound found in coriander and ginger may help protect against the negative effects of radiation exposure.

3 Oct 2017

FDA approves Verzenio for advanced metastatic breast cancer

The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

2 Oct 2017

Penn researchers develop predictive model to help lung cancer patients avoid ED visits

A pilot program that uses big data to predict which lung cancer patients will require a trip to an emergency department successfully anticipated a third of all ED visits over a two-week trial period, and was further able to identify which patients were at high risk and low risk of requiring such care.

27 Sep 2017

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.

27 Sep 2017

California scrambles to contain ‘unprecedented’ hepatitis A outbreaks

Health officials in California are struggling to contain fierce outbreaks of hepatitis A among homeless people and drug abusers in three counties, including San Diego, where at least 17 people have died.

26 Sep 2017

One-fourth of cancer patients use cannabis, study reveals

New research conducted in a cancer center in a state that had legalized the use of recreational and medicinal cannabis shown that about one-fourth of surveyed cancer patients used cannabis in the previous year, mostly for psychological and physical symptoms. The study also indicated that legalization increased the likelihood of a rise of cannabis use among cancer patients.

25 Sep 2017

Legalization increases likelihood for marijuana use among cancer patients, study reveals

A new study conducted in a cancer center in a state with legalized medicinal and recreational marijuana found that approximately one-quarter of surveyed patients used marijuana in the past year, mostly for physical and psychological symptoms.

25 Sep 2017

Study may provide insights into treating autism and other neuropsychiatric disorders

Alterations in a naturally occurring chemical in the brain called serotonin have been linked to a number of neuropsychiatric disorders including depression, anxiety, obsessive-compulsive disorder as well as autism spectrum disorder (ASD).

20 Sep 2017

Risk factors, symptoms, diagnosis and treatment of ovarian cancer

Ovarian cancer is the 9th most common cancer in women and although it only accounts for approximately 3 percent of cancers in women, it is responsible for the most deaths of any cancer involving the female reproductive tract.

20 Sep 2017

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.

14 Sep 2017

Intense sanitization effort as Hepatitis A outbreak in San Diego claims 16 lives

An outbreak of hepatitis A in San Diego is being investigated by the Public Health Services Division, in the County of San Diego Health and Human Services Agency. Most of the people affected with hepatitis A are the illicit drug users and homeless individuals. The spread from one person to another through fecal contamination.

14 Sep 2017

Campylobacter infection outbreak linked to puppies

There is a warning about a multi-state outbreak of human Campylobacter infections that seemed to have originated from the puppies sold through Petland, a national pet store chain.

11 Sep 2017

Gas Safety Trust conducts workshop to explore new ways for diagnosing CO poisoning

Diagnosing carbon monoxide poisoning is notoriously difficult, as it produces common, non-specific symptoms such as headaches and nausea and mimics other, more common ailments such as flu and food poisoning.

11 Sep 2017

Follow-up letters, FIT tests can help improve colon cancer screening completion

Sending a letter and, in some cases, a simple mail-in kit tripled colon cancer screening completion among low-income adults, researchers at UT Southwestern's Simmons Cancer Center report this week in JAMA.

8 Sep 2017

Janssen launches innovative campaign to bring much-needed attention to blood cancer across the UK

As part of Janssen’s commitment to raising awareness of blood cancer, supporting patients with the condition and their families, Janssen has today launched the Make Blood Cancer Visible campaign.

6 Sep 2017

Hepatitis A outbreak among population of San Diego

The San Diego population is facing one of the worst outbreaks of infective viral disease Hepatitis A. the outbreak began last November and is still going strong with no signs of reduction in the infection rates. The homeless are one of the worst hit.

3 Sep 2017

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML).

1 Sep 2017

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG (gemtuzumab ozogamicin) for adults with newly diagnosed CD33-positive acute myeloid leukemia (AML), and adults and children 2 years and older with relapsed or refractory CD33-positive AML.